Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ruthenium Catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel mixed-solvent synthesis for high-purity chiral diamine ruthenium catalysts. Reduces recrystallization needs and boosts yield for asymmetric catalysis applications.
Novel one-pot route for ruthenium-carbene compounds ensures high purity and cost reduction in catalyst manufacturing for global supply chains.
Patent CN108261793A details dialysis purification for ruthenium complexes ensuring high purity and scalable catalyst manufacturing for industrial applications.
Novel alkynol ligand ruthenium catalyst enables efficient ring-opening metathesis polymerization with simplified processing and enhanced supply chain reliability for industrial polymer manufacturing.
Novel ruthenium pincer catalyst enables direct amine synthesis from alcohols. Reduces waste and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Novel ruthenium catalysis for methyl ester selective dehydroboration. Offers significant cost reduction and supply chain reliability for high purity pharmaceutical intermediates manufacturing.
Novel chiral spirocyclic diphosphine ligand synthesis via patent CN1562926A. High enantioselectivity (98% ee) for asymmetric hydrogenation. Cost-effective supply chain solutions.
Patent CN102070383A details a green Ru-catalyzed oxidation of olefins to 1,2-diketones. Offers high selectivity, broad substrate scope, and cost-effective manufacturing for pharma intermediates.
Novel Ru-phosphine-nitrogen complexes enable efficient ketone reduction. Enhances supply chain reliability and reduces manufacturing costs for chiral intermediates.
Novel ruthenium catalyst method reduces cost and waste for Gliclazide side chain manufacturing ensuring high purity and supply chain stability for global buyers.
Patent CN117700326A reveals a novel Ruthenium catalyst for carbamate hydrogenation. This breakthrough enables cost reduction in fine chemical manufacturing and reliable supply chains.
Advanced ruthenium catalyst technology for cyclic carbonate hydrogenation. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN103502208B reveals mild diamine synthesis avoiding Birch reduction. Enables cost reduction in pharmaceutical intermediate manufacturing and supply chain reliability.
Patent CN110294689B details a green ruthenium-catalyzed method for converting primary amines to nitriles with high yield and hydrogen byproduct.
Novel copper-catalyzed substitution route for efficient ligand production enabling high-performance ruthenium dehydrogenation catalysts for pharmaceutical applications.
Patent CN111892528A details a regioselective Ru-catalyzed C-H amidation method, offering cost-effective routes for high-purity pharmaceutical intermediates and scalable API manufacturing.
Patent CN112675920B reveals a novel monochiral ruthenium catalyst enabling efficient asymmetric hydrogenation and kinetic resolution for high-purity pharmaceutical intermediates.
Patent CN100389877C details a novel PEG-supported ruthenium catalyst enabling ambient pressure asymmetric hydrogenation, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN111468191A details a safe, scalable phosphorus ylide route for Grubbs catalysts, offering cost reduction and supply chain stability for fine chemical manufacturing.
Discover how novel biphenyl-type tridentate ligand ruthenium complexes enable ester-to-alcohol hydrogenation at 60-100°C and 3-10MPa, reducing costs and safety risks for pharma production.